These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2867209)

  • 1. Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat.
    Roesler JM; McCafferty JP; DeMarinis RM; Matthews WD; Hieble JP
    J Pharmacol Exp Ther; 1986 Jan; 236(1):1-7. PubMed ID: 2867209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of SK&F 104078, a novel alpha-adrenoceptor antagonist, in normotensive and hypertensive rats.
    Hieble JP; Sulpizio AC; Gutzait L; Gombar CT
    J Cardiovasc Pharmacol; 1990 May; 15(5):845-52. PubMed ID: 1692947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    Ohlstein EH; Kruse LI; Ezekiel M; Willette RN
    J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular actions of a new selective postjunctional alpha-adrenoceptor antagonist, SK&F 104856, in normotensive and hypertensive dogs.
    Hieble JP; Nichols AJ; Fredrickson TA; DePalma PD; Ruffolo RR; Brooks DP
    Br J Pharmacol; 1992 Apr; 105(4):992-6. PubMed ID: 1354539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
    Schiffrin EL; Turgeon A; Deng LY
    Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the adrenoceptor antagonistic and antihypertensive activity of oral amosulalol, a combined alpha- and beta-adrenoceptor antagonist, in hypertensive rats.
    Inagaki O; Sudoh K; Shibasaki M; Nakagawa C; Honda K
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):794-802. PubMed ID: 7532758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive activity of tibalosine (CP 804 S) in the rat. Possible involvement of a central alpha 1-adrenergic receptor blockade.
    Chatelain P; Claeys M; van Dorsser W; Roba J
    Arch Int Pharmacodyn Ther; 1984 Apr; 268(2):271-86. PubMed ID: 6145397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular activity of SK&F 64139 in the hypertensive rat.
    Hieble JP; McCafferty JP; Roesler JM; Pendleton RG; Gessner G; Carey R; Sarau HM; Goldstein M
    J Cardiovasc Pharmacol; 1983; 5(5):889-97. PubMed ID: 6195482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].
    Kido H; Nishikawa M; Hayashi K; Kubo Y; Ohtaki Y; Fujino Y; Egi Y; Ebisu H; Inoue S; Yamanaga K; Uchida T; Nakamura N
    Nihon Yakurigaku Zasshi; 1997 Jun; 109(6):279-89. PubMed ID: 9253775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models.
    Tanaka M; Yamamoto S; Nakao K; Inukai T; Ogawa N; Katsumura H; Ohara N; Shukunobe K; Ono H
    Arzneimittelforschung; 1991 Jun; 41(6):608-12. PubMed ID: 1930348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
    Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
    Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
    Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
    Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alpha 1-adrenoceptor blockade on blood pressure and iliac vascular resistance in normotensive and Goldblatt hypertensive dogs; influence of dietary salt and DOCA-salt.
    Zeigler DW; Zimmerman BG
    J Hypertens; 1987 Aug; 5(4):407-12. PubMed ID: 2889779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
    Haruta K; Baba A; Akima M; Koga T; Shiraki Y; Sakai K
    Arch Int Pharmacodyn Ther; 1989; 299():169-84. PubMed ID: 2570554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.